Effects of febuxostat on markers of endothelial dysfunction and renal progression in patients with chronic kidney disease
Abstract Hyperuricemia relates to chronic kidney disease (CKD) progression and impaired endothelial function. Febuxostat is potent and effective for decreasing serum uric acid levels. Information for the effect of febuxostat treatment on markers of endothelial dysfunction and renal injury among pati...
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Nature Portfolio
2023-08-01
|
| Edice: | Scientific Reports |
| On-line přístup: | https://doi.org/10.1038/s41598-023-40767-5 |